Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-150,000
Closed -$11.5M 100
2021
Q4
$11.5M Sell
150,000
-100,000
-40% -$7.96M 1.68% 17
2021
Q3
$18.8M Hold
250,000
2.68% 9
2021
Q2
$19.4M Buy
250,000
+14,200
+6% +$1.06M 2.54% 10
2021
Q1
$17.3M Buy
235,800
+10,480
+5% +$773K 2.22% 11
2020
Q4
$17.6M Buy
225,320
+36,680
+19% +$2.81M 2.48% 8
2020
Q3
$14.9M Buy
188,640
+20,960
+13% +$1.64M 2.44% 7
2020
Q2
$12.4M Buy
167,680
+115,280
+220% +$8.68M 2.16% 11
2020
Q1
$3.85M Buy
+52,400
New +$4.12M 0.78% 28

Other funds holding MRK

Clark Estates Inc's MRK Position: Q1 2022 in Review

Clark Estates Inc sold out of Merck (MRK) in Q1 2022, closing a stake of 150,000 shares — an estimated $11.5M sold.

Clark Estates Inc first reported a position in MRK in Q1 2020 and held it in 8 quarters. The position peaked at $19.4M in Q2 2021. 2,953 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Clark Estates Inc reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
  • Clark Estates Inc sold 150,000 Merck shares in Q1 2022, an estimated $11.5M.
  • Clark Estates Inc first reported a position in Merck in Q1 2020 and held it in 8 quarters.
  • Clark Estates Inc's Merck position peaked at $19.4M in Q2 2021.
  • 2,953 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Clark Estates Inc's 13F filing for Q1 2022, filed 13 May 2022.